Mohit B. Chhabra
New Delhi, DL, India
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Amphiphilic Heparinoids as Potent Antiviral Agents against SARS-CoV-2.
Journal: Journal of medicinal chemistry
Published: July 12, 2024
Alterations in retrobulbar haemodynamics in thyroid eye disease.
Journal: Eye (London, England)
Published: January 01, 2023
SARS-CoV-2 triggers complement activation through interactions with heparan sulfate.
Journal: Clinical & translational immunology
Published: June 06, 2022
Ocular sequelae in severe COVID-19 recovered patients of second wave.
Journal: Indian journal of ophthalmology
Published: May 03, 2022
Clinico-Radiological-Pathological Correlation of Visual Loss in COVID-Associated Rhino-Orbito-Cerebral Mucormycosis.
Journal: Ophthalmic plastic and reconstructive surgery
Published: December 17, 2021
Structural Insights into Pixatimod (PG545) Inhibition of Heparanase, a Key Enzyme in Cancer and Viral Infections.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: November 25, 2021
Development of Improved Synthetic Routes to Pixatimod (PG545), a Sulfated Oligosaccharide-Steroid Conjugate.
Journal: Bioconjugate chemistry
Published: October 15, 2021
Rhino-Orbito-Cerebral-Mucormycosis During the COVID-19 Second Wave in 2021 - A Preliminary Report from a Single Hospital.
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: June 15, 2021
Role of intrastromal vancomycin in recalcitrant corneal abscess after phacoemulsification.
Journal: BMJ case reports
Published: May 25, 2021
Comparative Evaluation of Tears and Nasopharyngeal Swab for SARS-CoV-2 in COVID-19 Dedicated Intensive Care Unit Patients.
Journal: Ocular immunology and inflammation
Published: May 11, 2021
From Cancer to COVID-19: A Perspective on Targeting Heparan Sulfate-Protein Interactions.
Journal: Chemical record (New York, N.Y.)
Published: April 14, 2021
Last Updated: 09/26/2026